Spots Global Cancer Trial Database for A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets
Official Title: A Phase I Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets
Study ID: NCT06165822
Conditions
Study Description
Brief Summary: This is a single-center, open, single-dose, self-controlled phase I clinical trial to evaluate the effects of Itraconazole Capsules/Rifampicin Capsules on pharmacokinetics of TQB3909 tablets in vivo, and the safety of TQB3909 tablets and combined with Itraconazole Capsules/Rifampicin Capsules after single oral dose.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
The First People's Hospital of Changzhou, Changzhou, Jiangsu, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
